Hereditary Cancer Genetic Panel Testing: A Review of the Literature
Cancer genetic testing (CGT) is a powerful diagnostic test that improves cancer prevention and early detection among individuals at high genetic risk of cancer. Since the completion of the mapping of the Human Genome Project, CGT has become increasingly available in the clinical setting. However, as...
Main Authors: | Gillian P. Harris, Sadie P. Hutson |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-03-01
|
Series: | SAGE Open |
Online Access: | https://doi.org/10.1177/2158244019835936 |
Similar Items
-
Application of Multigene Panels Testing for Hereditary Cancer Syndromes
by: Airat Bilyalov, et al.
Published: (2022-10-01) -
Clinical usefulness of NGS multi-gene panel testing in hereditary cancer analysis
by: Federico Anaclerio, et al.
Published: (2023-02-01) -
Genetic testing for hereditary breast cancer in Poland: 1998–2022
by: Jacek Gronwald, et al.
Published: (2023-06-01) -
Hereditary Gastric Cancer: Single-Gene or Multigene Panel Testing? A Mono-Institutional Experience
by: Mariarosaria Calvello, et al.
Published: (2023-05-01) -
Increased Co-Occurrence of Pathogenic Variants in Hereditary Breast and Ovarian Cancer and Lynch Syndromes: A Consequence of Multigene Panel Genetic Testing?
by: Mar Infante, et al.
Published: (2022-09-01)